I think this is flat out incorrect, that we'd be able to replicate anywhere even near the level of sales through direct marketing that would be possible under an established pathology major like Sonic. Getting greater revenue per sale, without even taking into account the additional marketing costs of doing it internally, will certainly not replace the ability to pervade the market. After a period of lackluster direct sales under this proposed strategy, no doubt we would end up licensing to another healthcare provider like Sonic after its realized that this approach isnt working.
PIQ Price at posting:
62.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)